UPDATE – Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC
Key Highlights
- ➤Tevogen signs non-binding LoI to evaluate potential HRK Healthcare acquisition
- ➤Potential transaction could expand Tevogen’s healthcare services infrastructure capabilities
- ➤Strategic acquisitions could potentially support approximately $100 million combined annual revenue
- ➤Tevogen hopes proposed HRK transaction could close by end of Q4 2026
Expert Statements
Manmohan Patel, MD and Tevogen lead investor
“I am pleased with Tevogen’s continued progress toward building an integrated healthcare enterprise. The potential HRK transaction represents an opportunity to expand the Company’s healthcare services capabilities and advance its mission of improving the affordability and accessibility of life-saving medicines. If consummated, this opportunity, together with other strategic acquisition initiatives, could potentially pave Tevogen’s path to realizing approximately $100 million in combined annual revenue.”
Ryan Saadi, MD, MPH and Tevogen CEO
“If the process progresses as anticipated, we are hopeful that the proposed transaction could close by the end of the fourth quarter of 2026. This reflects our current aspirations, and there can be no assurance regarding the timing or completion of any transaction.”
WARREN, N.J., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Tevogen Inc. (“Tevogen” or the “Company”) (Nasdaq: TVGN), an integrated healthcare enterprise combining biopharma, artificial intelligence, and healthcare services to improve the affordability and accessibility of life-saving medicines, today announced that it has entered into a signed, non-exclusive, non-binding Letter of Intent (“LoI”) to evaluate a potential transaction with HRK Healthcare LLC (“HRK”).
If consummated, the proposed transaction could expand Tevogen’s healthcare infrastructure capabilities and support the Company’s evolution into a revenue-generating healthcare enterprise comprised of Tevogen Bio, its biopharma arm; Tevogen.AI, its technology arm; and, subject to completion of proposed transactions, a healthcare services arm that may include management services.
Get started
Create a free account to read the full story.